OBJECTIVE
To compare the clinical and microbiological outcome of a single-dose administration of cefuroxime or combined piperacillin/tazobactam (PT) after transrectal prostatic core-biopsy (TPB) in a prospective, randomized, open-label study.
PATIENTS AND METHODS
Of 111 eligible men consecutively undergoing ultrasonographically guided TPB, 56 received 1.5… (More)